ArticlebioRxiv : the preprint server for biology2025
Immunomodulation by AZD1656 reverses cardiac dysfunction, metabolic remodelling and reduces infarct size in type 2 diabetic cardiomyopathy.
Stephanie Anderson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.